NanoViricides Inc. (NNVC) |
|
2.31 0.102 (4.64%)
|
11-19 15:47 |
|
Open: |
2.2 |
Pre. Close: |
2.2076 |
|
High:
|
2.4 |
Low:
|
2.15 |
|
Volume:
|
13,465 |
Market Cap:
|
9M |
|
|
|
|
Nanoviricides Inc is a development stage nano-biopharmaceutical company. Its business activities are to discover, develop and commercialize therapeutics to take care of patients suffering from life-threatening viral infections. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.403 - 2.413 |
2.413 - 2.422 |
|
Low:
|
2.128 - 2.138 |
2.138 - 2.147 |
|
Close:
|
2.383 - 2.4 |
2.4 - 2.416 |
|
Technical analysis |
as of: 2019-11-19 4:28:34 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 3.20 One year: 3.74 |
| Support: |
Support1: 2.07  Support2: 1.65 |
| Resistance: |
Resistance1: 2.74 Resistance2: 3.20 |
| Pivot: |
2.12 |
| Moving Average: |
MA(5): 2.21 MA(20): 2.18 
MA(100): 3.53 MA(250): 4.96 |
| MACD: |
MACD(12,26): -0.06 Signal(9): -0.11 |
| Stochastic oscillator: |
%K(14,3): 57.19 %D(3): 46.48 |
| RSI: |
RSI(14): 55.09 |
| 52-week: |
High: 13.60 Low: 1.27 Change(%): -63.6 |
| Average Vol(K): |
3-Month: 4655 10-Days: 1307 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.NNVC has closed above the upper band by 9.9%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 57.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to NNVC's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
2019-10-03
NanoViricides is Creating Nanomedicines to Develop Antiviral Therapies to Combat Shingles and Herpes Viruses Interviewing with Proactive Investors, President & Chairman Anil R. Diwan Outlines the History and Cutting Edge Technology Driving Proprietary Therapies
SHELTON, CT / ACCESSWIRE / October 3, 2019 / NanoViricides, Inc., (NYSE American:NNVC) (the "Company"), a leader in developing novel nanomedicines to treat viral diseases, based on the nanoviricides® platform, announces that Anil R. Diwan, PhD, President and Executive Chairman, was interviewed
2019-09-12
NanoViricides, Inc. Announces One-for-Twenty Reverse Stock Split
SHELTON, Conn., Sept. 12, 2019 /PRNewswire/ -- NanoViricides, Inc. (NYSE Amer.: NNVC) (the "Company"), announced today that its Board of Directors has approved a 1-for-20 reverse split of all of the Company's capital stock, including its common stock, which will be effective after the market
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE American |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
3.84 |
| Shares Float (M) |
2.73 |
|
% Held by Insiders
|
28.05 |
|
% Held by Institutions
|
5.03 |
|
Shares Short (K)
|
11 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-2.400 |
|
Book Value (p.s.)
|
2.760 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-33.8 |
|
Return on Equity (ttm)
|
-59.6 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-2.073 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-6.80 |
|
Levered Free Cash Flow (M)
|
-2.32 |
Stock Valuations |
|
P/E
|
|
|
P/E Growth Ratio
|
0.09 |
|
P/BV
|
0.87 |
|
P/S
|
|
|
P/CF
|
-1.36 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
2019-09-24 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
